EXTRACELLULAR RECORDINGS OF MEMBRANE-POTENTIAL FROM GUINEA-PIG ISOLATED TRIGEMINAL GANGLION - LACK OF EFFECT OF SUMATRIPTAN

被引:17
作者
OSHAUGHNESSY, CT
CONNOR, HE
FENIUK, W
机构
[1] Department of Neuropharmacology, Glaxo Group Research Ltd., Ware
关键词
D O I
10.1046/j.1468-2982.1993.1303175.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The aim of this study was to investigate the effect of the anti-migraine drug and selective 5-HT1 receptor agonist, sumatriptan, on membrane potential of. guinea-pig isolated trigeminal ganglion. Ganglia were divided into three longitudinally, placed in two-compartment baths and the d.c. potential between compartments was recorded extracellularly. Drugs were applied to the Krebs superfusion fluid of one compartment. KCl (3 mmol/l) and GABA (0.1 mmol/l) caused depolarization (0.30 +/- 0.05 and 0.55 +/-0.08 mV respectively, n = 11-19). 5-HT (1-10 mumol/l) caused small depolarizations (0.06 +/- 0.02 mV, n = 8) but sumatriptan (0.1 - 10 mumol/l) had no effect on trigeminal ganglion membrane potential. Collagenase pretreatment, to enhance desheathing, or modification of the composition of the Krebs solution failed to reveal any effect of sumatriptan. These data provide no evidence to suggest that sumatriptan inhibits neurotransmission in trigeminal ganglion. However, 5-HT1 receptors may be present in insufficient numbers in the trigeminal ganglion to elicit a change in membrane potential. Further studies are required to investigate the effect of sumatriptan at the level of the sensory nerve terminals within the intracranial vasculature, where 5-HT1 receptors may be concentrated.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 26 条
[1]   EVIDENCE FOR THE PRESENCE OF 5-HT(1B) RECEPTOR MESSENGER-RNA IN NEURONS OF THE RAT TRIGEMINAL GANGLIA [J].
BRUINVELS, AT ;
LANDWEHRMEYER, B ;
MOSKOWITZ, MA ;
HOYER, D .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (03) :357-359
[2]   DIHYDROERGOTAMINE AND SUMATRIPTAN ATTENUATE LEVELS OF CGRP IN PLASMA IN RAT SUPERIOR SAGITTAL SINUS DURING ELECTRICAL-STIMULATION OF THE TRIGEMINAL GANGLION [J].
BUZZI, MG ;
CARTER, WB ;
SHIMIZU, T ;
HEATH, H ;
MOSKOWITZ, MA .
NEUROPHARMACOLOGY, 1991, 30 (11) :1193-1200
[3]   5-HYDROXYTRYPTAMINE RECEPTOR AGONISTS FOR THE ABORTIVE TREATMENT OF VASCULAR HEADACHES BLOCK MAST-CELL, ENDOTHELIAL AND PLATELET ACTIVATION WITHIN THE RAT DURA-MATER AFTER TRIGEMINAL STIMULATION [J].
BUZZI, MG ;
DIMITRIADOU, V ;
THEOHARIDES, TC ;
MOSKOWITZ, MA .
BRAIN RESEARCH, 1992, 583 (1-2) :137-149
[4]   THE ANTIMIGRAINE DRUG, SUMATRIPTAN (GR43175), SELECTIVELY BLOCKS NEUROGENIC PLASMA EXTRAVASATION FROM BLOOD-VESSELS IN DURA MATER [J].
BUZZI, MG ;
MOSKOWITZ, MA .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (01) :202-206
[5]   TREATMENT OF ACUTE MIGRAINE WITH SUBCUTANEOUS SUMATRIPTAN [J].
CADY, RK ;
WENDT, JK ;
KIRCHNER, JR ;
SARGENT, JD ;
ROTHROCK, JF ;
SKAGGS, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (21) :2831-2835
[6]   CHARACTERIZATION OF 5-HT RECEPTORS MEDIATING CONTRACTION OF CANINE AND PRIMATE BASILAR ARTERY BY USE OF GR43175, A SELECTIVE 5-HT1-LIKE RECEPTOR AGONIST [J].
CONNOR, HE ;
FENIUK, W ;
HUMPHREY, PPA .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) :379-387
[7]  
EDVINSSON L, RETROGRADE TRACING N
[8]  
Edvinsson L, 1986, NEURAL REGULATION BR, P407
[9]   SUBCUTANEOUS SUMATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE [J].
ENSINK, FBM .
JOURNAL OF NEUROLOGY, 1991, 238 :S66-S69
[10]  
FERRARI MD, 1991, NEW ENGL J MED, V325, P316